Your browser doesn't support javascript.
loading
The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
Fang, Wentao; Girard, Nicolas; Cilento, Vanessa; Goren, Emily; Dibaba, Daniel; Ruffini, Enrico; Ahmad, Usman; Appel, Sarit; Bille, Andrea; Boubia, Souheil; Brambilla, Cecilia; Cangir, Ayten Kayi; Detterbeck, Frank; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Guerrera, Francesco; Huang, James; Infante, Maurizio; Kim, Dong Kwan; Lucchi, Marco; Marino, Mirella; Marom, Edith M; Nicholson, Andrew G; Okumura, Meinoshin; Rami-Porta, Ramon; Rimner, Andreas; Simone, Charles B; Asamura, Hisao.
Affiliation
  • Fang W; Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
  • Girard N; Institut Curie, Paris, France.
  • Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Goren E; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Dibaba D; Cancer Research And Biostatistics (CRAB), Seattle, Washington.
  • Ruffini E; University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it.
  • Ahmad U; Thoracic Surgery in the Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Appel S; Sheba Medical Center, Ramat Gan, Israel.
  • Bille A; Guy's Hospital, London, United Kingdom.
  • Boubia S; University Hospital Ibn Rochd, Casablanca, Morocco.
  • Brambilla C; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Cangir AK; Ankara University Faculty of Medicine, Ankara, Turkey.
  • Detterbeck F; Yale University School of Medicine, New Haven, Connecticut.
  • Falkson C; Queen's University at Kingston, Ontario, Canada.
  • Filosso PL; Baggiovara Civil Hospital, University of Modena, Modena, Italy.
  • Giaccone G; Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.
  • Guerrera F; University of Torino, Torino, Italy.
  • Huang J; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Infante M; University and Hospital Trust, Verona, Italy.
  • Kim DK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lucchi M; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Marino M; IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Marom EM; Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.
  • Nicholson AG; Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Okumura M; National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.
  • Rami-Porta R; Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.
  • Rimner A; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Simone CB; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Asamura H; Keio University, Tokyo, Japan.
J Thorac Oncol ; 19(1): 52-70, 2024 01.
Article in En | MEDLINE | ID: mdl-37774950
ABSTRACT

INTRODUCTION:

Stage classification is an important underpinning of management in patients with cancer and rests on a combination of three components-T for tumor extent, N for nodal involvement, and M for distant metastases. This article details the revision of the N and the M components of thymic epithelial tumors for the ninth edition of the TNM classification of malignant tumors proposed by the Thymic Domain of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee.

METHODS:

The N and M components of the eighth edition staging system were verified by a large international collaborative data source through a data-driven analysis. A total of 9147 cases were included for analysis, including 7662 thymomas, 1345 thymic carcinomas, and 140 neuroendocrine thymic tumors.

RESULTS:

Lymph node involvement rates were 1.5% in thymomas and 17.6% and 27.7% in thymic carcinomas and neuroendocrine thymic tumors, respectively. Rates of lymph node metastasis were increasingly higher in tumors with higher T stage and higher-grade histologic type. Survival analysis validated the differences in the N and M categories proposed in the eighth edition staging system. Good discrimination in overall survival was detected among pathologic (p)N and pM categories in patients with thymoma and thymic carcinoma.

CONCLUSIONS:

No changes are proposed from the eighth edition for the N and M components. The proposed stage classification will provide a useful tool for management of the disease among the global thymic community.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Neuroendocrine Tumors / Neoplasms, Glandular and Epithelial / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymoma / Thymus Neoplasms / Neuroendocrine Tumors / Neoplasms, Glandular and Epithelial / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Thorac Oncol Year: 2024 Document type: Article
...